| __timestamp | Supernus Pharmaceuticals, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 122045000 | 759285000 |
| Thursday, January 1, 2015 | 144427000 | 862944000 |
| Friday, January 1, 2016 | 215003000 | 950751000 |
| Sunday, January 1, 2017 | 302238000 | 879387000 |
| Monday, January 1, 2018 | 408897000 | 661913000 |
| Tuesday, January 1, 2019 | 392755000 | 669893000 |
| Wednesday, January 1, 2020 | 520397000 | 644769000 |
| Friday, January 1, 2021 | 579775000 | 548970000 |
| Saturday, January 1, 2022 | 667238000 | 561347000 |
| Sunday, January 1, 2023 | 607521000 | 572952000 |
| Monday, January 1, 2024 | 629182000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding revenue trends is crucial. Supernus Pharmaceuticals, Inc. and Taro Pharmaceutical Industries Ltd. have shown distinct revenue trajectories from 2014 to 2023. Supernus Pharmaceuticals experienced a remarkable growth, with revenue increasing by over 400% from 2014 to 2022, peaking in 2022. However, 2023 saw a slight dip, indicating potential market challenges or strategic shifts. In contrast, Taro Pharmaceutical Industries Ltd. maintained a more stable revenue stream, with a slight decline of about 25% from its peak in 2016 to 2023. This stability suggests a consistent market presence despite industry fluctuations. Notably, data for 2024 is incomplete, highlighting the need for ongoing analysis. These insights provide a window into the strategic maneuvers and market dynamics influencing these pharmaceutical giants.
Revenue Showdown: Novartis AG vs Taro Pharmaceutical Industries Ltd.
Revenue Insights: Gilead Sciences, Inc. and Supernus Pharmaceuticals, Inc. Performance Compared
Revenue Showdown: BeiGene, Ltd. vs Supernus Pharmaceuticals, Inc.
Breaking Down Revenue Trends: BeiGene, Ltd. vs Taro Pharmaceutical Industries Ltd.
Who Generates More Revenue? Lantheus Holdings, Inc. or Taro Pharmaceutical Industries Ltd.
Breaking Down Revenue Trends: Ionis Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Comparing Revenue Performance: TG Therapeutics, Inc. or Supernus Pharmaceuticals, Inc.?
Revenue Insights: TG Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. Performance Compared
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Galapagos NV?
Comparing Revenue Performance: Supernus Pharmaceuticals, Inc. or Evotec SE?
Mesoblast Limited or Taro Pharmaceutical Industries Ltd.: Who Leads in Yearly Revenue?
Annual Revenue Comparison: Taro Pharmaceutical Industries Ltd. vs MiMedx Group, Inc.